ever
increas
resist
human
pathogen
current
antiinfect
agent
seriou
medic
problem
lead
need
develop
novel
antibiot
prototyp
molecul
case
virus
search
antivir
agent
involv
addit
difficulti
particularli
due
natur
infecti
viral
agent
thu
mani
compound
may
caus
death
virus
also
like
injur
host
cell
haibour
natur
product
increasingli
appreci
lead
drug
discoveri
develop
screen
studi
carri
order
find
antivir
agent
natur
sourc
occurr
antivir
activ
extract
plant
marin
organ
fungi
frequent
evid
indic
may
numer
potenti
usefiil
antivir
phytochem
natur
wait
evalu
exploit
addit
plant
previous
util
medicin
may
also
reveal
antivir
among
natur
antivir
agent
recent
investig
reconsid
interest
phytopolysaccharid
act
potent
inhibitor
differ
virus
chapter
illustr
varieti
antivir
polysaccharid
natur
sourc
sinc
aim
make
matter
access
drug
develop
infecti
diseas
account
onethird
death
worldwid
although
last
decad
yield
signific
advanc
treatment
infecti
diseas
new
therapi
viral
fungal
bacteri
parasit
infect
need
virus
respons
larg
proport
morbid
mortahti
experienc
worldwid
infecti
agent
consist
core
genom
nucleic
acid
dna
rna
nucleoid
contain
protein
shell
capsid
sometim
surround
lipoprotein
membran
envelop
genera
virus
known
caus
human
infect
includ
follow
adeno
pox
herpesvirus
herp
simplex
viru
type
varicellazost
cytomegaloviru
epsteinbarr
viru
papillomavirus
papilloma
cancer
parvovirus
erythema
infectiosum
dnavirus
eg
hepat
b
rna
virus
reoand
rotaviru
rna
virus
influenza
parainfluenza
measl
respiratori
syncyti
vesicular
stomat
rabi
viru
togavirus
rubella
yellow
fever
retrovirus
eg
human
immunodefici
viru
caus
agent
acquir
immunodefici
syndrom
sever
rna
virus
arenavirus
lymphocyt
choriomening
bunyavirus
enceph
coronavirus
upper
respiratori
infect
picornavirus
poliomyel
diarrhoea
success
antiinfect
agent
inhibit
essenti
step
metabol
process
requir
pathogen
absent
host
hovev
virus
replic
independ
must
enter
cell
use
cellular
energygener
dnaor
rnarepl
proteinsynthes
pathway
host
achiev
viral
replic
reason
case
virus
search
antivir
agent
hard
sinc
metabol
differ
avail
virus
util
host
protein
synthesi
leav
aspect
nucleic
acid
synthesi
macromolecul
process
distinct
host
metabol
identif
retroviru
human
immunodefici
viru
caus
agent
acquir
immunodefici
syndrom
steadili
increas
incid
variou
viral
infect
caus
virus
immunodefici
patient
e
g
herp
simplex
viru
varicellazost
viru
cytomegaloviru
epsteinbarr
viru
increas
evid
pathogen
role
number
virus
eg
human
papilloma
viru
pathogenesi
primari
hepatocellular
carcinoma
socioeconom
impact
viral
infect
respiratori
influenza
adeno
coronaand
rhinovirus
gastrointestin
tract
rotavirus
import
factor
boost
search
new
antivir
agent
new
modal
antivir
chemotherapi
although
mani
compound
potent
antivir
activ
cell
cultur
experiment
anim
detect
present
sever
molecul
ainterferon
approv
health
author
therapi
viral
infect
human
among
antivir
substanc
sever
natur
compound
isol
plant
use
tradit
medicin
includ
polysaccharid
polysaccharid
ps
constitut
stmctural
divers
class
biolog
macromolecul
wide
rang
physicochem
properti
basi
differ
applic
broad
field
pharmaci
medicin
sever
hundr
natur
ps
current
known
provid
one
richest
oldest
reservoir
structur
function
divers
biopolym
ps
constitut
import
member
famili
industri
watersolubl
polym
besid
classic
applic
biopolym
industri
pharmaceut
practic
rel
new
field
pharmacolog
activ
polym
discuss
ps
plant
natur
sourc
long
known
exert
antitumour
immunomodulatori
anticoagul
type
biolog
activ
includ
antivir
activ
import
plant
kingdom
sourc
new
antivir
substanc
illustr
present
survey
naturalderiv
antivir
ps
recent
year
natur
synthet
polym
carbohydr
natur
prove
select
inhibitor
sever
envelop
virus
includ
human
pathogen
human
immunodefici
viru
herp
simplex
viru
human
cytomegaloviru
influenza
viru
respiratori
syncyti
viru
recent
effort
direct
develop
polysaccharid
molecul
select
inhibitor
differ
class
virus
search
follow
molecular
target
envisag
dna
virus
gener
viral
dna
polymeras
herp
simplex
viru
varicellazost
viru
viral
dna
polymeras
via
specif
phosphoryl
viral
kinas
rna
rna
virus
sadenosylhomocystein
hydrolas
key
enzym
transmethyl
reaction
requir
matur
viral
mrna
retrovirus
revers
transcriptas
initi
viru
replic
andor
cell
transform
sever
envelop
virus
eg
retro
herpesand
rhabdovirus
viru
adsorpt
outer
cell
membran
review
deal
antivir
ps
compil
sever
sourc
past
decad
respect
titl
offer
brief
descript
import
global
viral
infect
caus
either
individu
virus
group
relat
virus
restrict
gener
consid
import
human
veterinari
medicin
report
activ
antivir
ps
record
literatur
acquir
immunodefici
syndrom
aid
pandem
immunosuppress
diseas
result
lifethreaten
opportunist
infect
malign
number
aid
infect
million
million
peopl
half
africa
kill
diseas
worldwid
order
combat
human
immunodefici
viru
hiv
caus
agent
aid
enorm
amount
time
money
dedic
research
compound
develop
therapeut
agent
hiv
lentiviru
replic
within
critic
cell
immun
system
particularli
tcell
monocytemacrophag
lead
progress
loss
helper
tcell
profound
immunosuppress
condit
known
aid
without
treatment
tlymphocyt
infect
patient
reduc
markedli
patient
suscept
wide
rang
opportunist
infect
ultim
die
sinc
retroviru
design
hiv
clearli
identifi
primari
caus
diseas
numer
compound
also
includ
plantderiv
substanc
evalu
inhibitori
effect
hiv
replic
vitro
furthermor
mani
plant
product
use
patient
aid
countri
without
scientif
proof
possess
antihiv
activ
sever
review
natur
product
chemotherapi
hiv
infect
record
literatur
carbohydr
among
natur
molecul
capabl
treat
hiv
infect
variou
ps
includ
sulphat
ps
found
antihiv
activ
substanc
mani
antivir
activ
plant
extract
medicin
plant
use
tradit
medicin
antiinfect
exampl
ps
isol
aqueou
extract
plant
hyssop
officinali
l
found
inhibit
replic
demonstr
inhibit
antigen
syncytia
format
aspalatho
lineari
burm
popular
medicin
plant
south
africa
europ
japan
ps
strong
antihiv
activ
isol
compound
almost
complet
inhibit
bind
cell
major
sugar
compon
purifi
ps
found
glucos
galactos
mannos
xylos
premanathan
et
al
investig
ps
extract
rizophora
apiculata
blume
rizophora
mucronata
poir
cell
cultur
system
activ
human
simian
immunodefici
virus
siv
compound
inhibit
siv
strain
variou
cell
cultur
assay
system
found
ps
consist
mainli
neutral
sugar
uron
acid
screen
program
thai
plant
antihiv
activ
found
extract
speci
belong
famili
show
activ
effect
sampl
extract
merremia
peltata
l
merril
activ
antihiv
agent
found
anion
ps
furthermor
sulphat
deriv
paramylon
pdglucan
euglena
gracili
kleb
significantli
inhibit
cytopath
effect
two
natur
occur
ps
isol
tropic
climb
shrub
ipomoea
cairica
l
sweet
found
strongli
inhibit
replic
vitro
accord
de
clercq
replic
cycl
hiv
compris
sever
step
could
consid
adequ
target
chemotherapeut
intervent
viru
entri
viral
adsorpt
viruscel
fusion
revers
rna
dna
transcript
provir
dna
integr
viral
dna
ea
transcript
transactiv
viral
mrna
protein
translat
viru
releas
viral
assembl
bud
matur
notabl
differ
hiv
replic
retrovirus
intric
control
hiv
gene
express
viral
cellular
factor
possibl
mechan
hiv
kill
infect
cell
includ
formul
multinucl
syncytia
cytopath
compon
within
virion
interact
viral
envelop
protein
molecul
cell
surfac
three
hiv
enzym
essenti
life
cycl
viru
hiv
revers
transcriptas
crucial
viral
replic
hiv
proteas
process
viral
polyprotein
fonction
enzym
structur
protein
therebi
facilit
matur
infect
virion
particl
hiv
integras
mediat
hiv
integr
host
chromosom
chemotherapeut
strategi
therefor
focus
develop
inhibitor
retrovir
enzym
recent
report
biolog
membran
aris
hivinduc
cell
fusion
well
syncytium
format
infect
noninfect
cell
interest
approach
research
new
hiv
therapi
natur
sulphat
ps
dextran
sulphat
pentosan
sulphat
chondroitin
sulphat
heparin
long
recogn
effect
antihiv
agent
compound
target
interact
viral
envelop
glycoprotein
receptor
consequ
inhibit
vim
adsorpt
cell
also
virusinduc
syncytium
giant
cell
format
inhibitori
effect
dextran
sulphat
congen
viral
bind
viral
replic
syncytium
format
appear
mediat
specif
interact
region
addit
sulphat
ps
may
also
directli
interfer
bind
hiv
particl
heparin
sulphat
proteoglycan
cell
surfac
whether
process
occur
independ
cooper
viral
envelop
receptor
interact
class
antivir
agent
exhibit
sever
uniqu
properti
share
current
known
antivir
agent
remark
broadspectrum
antivir
activ
seri
envelop
virus
abil
inhibit
syncytium
format
hivinfect
normal
tlymphocyt
mechan
drastic
enhanc
hiv
infect
low
induct
viral
drugresist
note
sulphat
ps
owe
antihiv
activ
presenc
sulphat
group
turn
respons
inhibit
viruscel
bind
dextran
highmolecularweight
ps
consist
predominantli
link
dglucos
unit
dextran
differ
chain
length
degre
branch
branch
occur
via
branch
point
dextran
fraction
differ
averag
molecular
weight
obtain
partial
hydrolysi
differ
fraction
sulphat
obtain
dextran
sulphat
differ
molecular
weight
busso
resnick
investig
effect
three
molecular
weight
rang
dextran
sulphat
five
differ
hiv
isol
higher
molecular
weight
rang
dextran
sulphat
show
potent
activ
assess
quantit
syncytium
format
assay
howev
dextran
sulphat
poorli
adsorb
oral
administr
upon
intraven
administr
produc
thrombocytopenia
littl
evid
vivo
efficaci
compound
gener
sulphat
ps
hiv
infect
howev
doubleblind
placebocontrol
clinic
pilot
trial
advanc
hiv
diseas
conduct
compound
summari
compound
offer
great
promis
candid
drug
chemotherapi
hiv
infect
novel
sulphat
ps
prove
potent
select
inhibitor
hiv
vitro
chemic
synthes
hand
although
sever
group
report
sulphat
ps
potent
select
inhibitor
hiv
therapeut
applic
howev
limit
anticoagul
activ
view
possibl
improv
therapeut
potenti
number
heparin
deriv
reduc
anticoagul
activ
studi
inhibitori
activ
hivdepend
syncytium
format
assay
pronounc
antihiv
activ
observ
succinyl
standard
heparin
succinyl
low
molecular
weight
heparin
similarli
order
increas
ratio
antihiv
activ
anticoagul
activ
select
substitut
sulphat
ps
oh
andor
cooh
group
chemic
prepar
group
compris
famili
heterogen
carbohydr
compos
long
unbranch
ps
modifi
exampl
sulphat
acetyl
acetyl
deriv
activ
inhibitor
hivinduc
giantcel
format
furthermor
sever
solubl
derivat
dextran
differ
percentag
carbomethyl
benzylamid
sulphonatesulph
group
also
evalu
possibl
inhibitori
effect
infect
result
obtain
use
antihiv
therapeut
agent
propos
natur
sourc
antihiv
sulphat
ps
includ
alga
marin
organ
sulphat
ps
found
varieti
marin
anim
plant
microorgan
aqueou
extract
mani
marin
invertebr
exhibit
activ
nation
cancer
institut
primari
screen
antihiv
cytopath
carrageenan
fucoidan
sulphat
ps
extract
red
seawe
brown
alga
shown
potent
inhibitori
activ
differ
virus
includ
hiv
exampl
fucoidan
complex
sulphat
ps
alga
fucu
vesiculosu
l
found
inhibit
hiv
vitro
presum
direct
interact
ps
hiv
bind
site
target
cell
aqueoussolubl
extract
alga
common
littor
alga
coast
northern
atlant
pacif
ocean
baltic
sea
inhibit
activ
hiv
revers
transcriptas
enzym
well
hivinduc
syncytium
format
beress
et
al
report
new
procedur
isol
antihiv
ps
marin
alga
novel
sulphat
ps
name
calcium
spirulan
isol
antivir
principl
spirulina
platensi
nordst
geitl
bluegreen
alga
grow
african
central
south
american
lake
rich
salt
chemic
analys
calcium
spirulan
suggest
contain
rhamnos
ribos
mannos
fructos
galactos
xylos
glucos
glucuron
acid
galacturon
acid
sulphat
ps
marin
sourc
demonstr
antivir
activ
hiv
block
viral
replic
cell
cultur
without
toxic
host
cell
exampl
includ
sulphat
cellwal
ps
mediterranean
red
alga
asparagopsi
armata
harvey
marin
microalga
cochlodinium
polykrikoid
bloom
fiicos
main
compon
sugar
ps
isol
brown
alga
sargasum
horneri
turner
c
agardh
sargasum
muticum
yendo
fensholt
sulphat
ps
brazilian
marin
alga
laminaria
abyssali
ab
joli
ec
oliveira
tropic
marin
alga
codiacea
famili
new
sulphat
pgalactan
marin
clam
speci
meretrix
petechiali
lamarck
natur
sourc
antihiv
sulphat
ps
includ
fiingi
ganoderma
lucidum
fr
karst
lentinu
edod
lem
mycelia
inhibit
hivrevers
transcriptas
hivrt
current
consid
usefiil
approach
prophylaxi
intervent
aid
natur
product
yet
extens
explor
inhibitor
enzym
furthermor
mechan
action
sulphat
ps
may
due
inhibit
viru
cell
adhes
also
inhibit
hivrt
herp
infect
ubiquit
approxim
popul
seroposit
infect
herp
simplex
viru
type
herp
simplex
viru
type
ii
varicellazost
viru
respect
alarmingli
past
decad
incid
sever
infect
caus
hsv
increas
due
growth
number
immunocompromis
patient
produc
aggress
chemotherapi
regimen
expand
organ
transplant
greater
occurr
hiv
infect
unfortun
prolong
therapi
acyclovir
success
antiherpet
drug
result
undesir
complic
also
induc
emerg
drugresist
virus
chang
diseas
pattern
increas
drug
use
frequenc
acyclovirresist
hsv
infect
emerg
infect
hsv
rang
simpl
cold
sore
fever
blister
sever
central
nervou
system
disord
develop
effect
antivir
medic
made
prompt
recognit
import
primari
care
practic
appropi
therapi
significantli
reduc
medic
psychosoci
ramif
herp
infect
greatli
improv
qualiti
life
mani
patient
thu
urgent
need
novel
antihsv
agent
especi
differ
mode
action
acyclovir
past
decad
addit
varieti
synthet
antivir
drug
differ
molecular
target
larg
number
phytochem
recogn
control
infect
caus
virus
belong
herpesvirida
famili
ethnopharmacolog
screen
medicin
plant
world
led
select
sever
extract
activ
herp
virus
among
natur
antivir
agent
recent
investig
reviv
interest
phytop
act
potent
inhibitor
differ
envelop
virus
includ
member
herpesvirida
exampl
neutral
ps
extract
sclerotium
glucanicum
halleck
name
scleroglucan
reveal
promis
antivir
activ
ps
compos
glucopyranos
backbon
singl
glucopyranosyl
branch
everi
third
subunit
blockag
hsv
infect
take
place
earli
phase
viral
multipl
cycl
sinc
greatest
inhibitori
effect
occur
ad
attach
step
result
intens
search
antivir
substanc
medicin
plant
antivir
activ
hsv
found
extract
cedrela
tubiflora
bertoni
leav
prunella
vulgari
l
perenni
plant
commonli
found
china
british
isl
europ
trichilia
glabra
l
leav
phytochem
studi
indic
plant
contain
anion
ps
activ
constitu
may
inhibit
hsv
compet
cell
receptor
well
unknown
mechan
viru
penetr
cell
furthermor
vitro
antivir
activ
demonstr
extract
medicin
plant
achyroclin
flaccida
weinm
dc
exert
earli
viral
replic
essenti
viral
adsorpt
host
cell
bioguid
purif
process
indic
neg
charg
ps
respons
antivir
activ
among
natur
antivir
agent
carbohydr
natur
recent
investig
also
reviv
interest
sulphat
phytop
carrageenan
fucoidan
seawe
sea
alga
repres
interest
sourc
potenti
antivir
compound
particularli
watersolubl
sulphat
ps
abund
constitu
cell
wall
compound
act
potent
inhibitor
differ
envelop
virus
includ
member
herpesvirida
activ
link
anion
featur
molecul
hinder
attach
viral
particl
host
cell
exampl
carrageenan
sulphat
galactan
extract
certain
red
seawe
compris
broad
rang
structur
divid
two
famili
kfamili
defin
presenc
group
pdunit
xfamili
character
sulphat
constitut
variat
structur
investig
detect
antivir
activ
signific
number
alga
variou
marin
environ
california
unit
kingdom
mediterranean
india
japan
cours
screen
studi
biolog
properti
natur
marin
product
divers
carrageenan
isol
red
seawe
gigartina
skottsbergii
setch
et
gard
prove
potent
inhibitor
vitro
mode
action
studi
consist
carrageenan
major
effect
attach
viru
cell
adsorpt
primarili
mediat
envelop
glycoprotein
gc
bind
heparan
sulphat
residu
present
proteoglycan
surfac
target
cell
antiherpet
activ
directli
correl
amount
adgalactos
residu
natur
carrageenan
carrageenan
also
isol
chilean
sampl
stenogramm
interrupta
c
ag
mont
red
seawe
california
cours
screen
antivir
properti
sulphat
ps
isol
marin
alga
south
american
coast
carlucci
et
ah
report
antivir
activ
mannan
xylogalactan
isol
red
seawe
nothogenia
fastigiata
turner
lam
sulphat
galactan
pterocladia
capillacea
gmelim
barnet
thuset
sensit
virus
compound
due
inhibit
viru
bind
structur
analysi
two
xylomannan
extract
nothogenia
fastigiata
carri
result
consist
gener
pattern
previous
report
xylomannan
system
l
link
dmannan
singl
stub
p
l
link
dxylos
one
new
sampl
contain
signific
amount
unit
presenc
sulphat
group
molecul
essenti
antivir
properti
ps
antivir
activ
sulphat
ps
known
increas
molecular
weight
degre
sulphat
howev
sulphat
ps
gener
endow
anticoagul
properti
may
hamper
use
antivir
drug
duart
et
al
report
inhibitori
effect
sulphat
galactan
marin
alga
bostrychia
montagriei
harvey
result
activ
partial
thromboplastin
time
assay
thrombin
time
assay
indic
three
natur
sulphat
ps
low
anticoagul
activ
confirm
relat
antivir
anticoagul
properti
antihsv
sulphat
ps
also
isol
seawe
rhamnan
sulphat
monostroma
latissimum
wittrock
calcium
spirulan
bluegreen
alga
spirulina
platensi
lee
et
al
initi
studi
structureact
relationship
calcium
spirulan
calcium
ion
bind
anion
part
molecul
replac
variou
metal
cation
replac
calcium
ion
sodium
potassium
ion
maintain
activ
dival
trival
cation
reduc
activ
cell
wall
sulphat
ps
red
microalga
porphyridium
spp
honey
exhibit
impress
antivir
activ
vitro
cell
cultur
vivo
rat
rabbit
seem
ps
abl
inhibit
viral
infect
prevent
adsorpt
viru
host
cell
andor
inhibit
product
new
viral
particl
insid
host
cell
novel
fiican
sulphat
antihsv
activ
also
isol
hot
water
extract
edibl
brown
alga
sargassum
horneri
brown
seawe
leathesia
difformi
linnaeu
areschong
natur
sourc
antihsv
ps
includ
fimgi
eg
variou
protein
bound
ps
isol
ganoderma
lucidum
basidiomycet
fungu
use
treat
human
diseas
orient
folk
medicin
possibl
mode
antivir
activ
ps
seem
relat
bind
hsvspecif
glycoprotein
respons
attach
penetr
imped
complex
interact
virus
cell
plasma
membran
furthermor
differ
semisynthet
ps
evalu
inhibitori
effect
vitro
replic
neutral
neg
charg
carbohydr
abl
inhibit
viral
infect
interf
mainli
adsorpt
process
vitro
vivo
effect
sulphat
ps
also
investig
pseudorabi
viru
suid
notabl
porcin
hsv
welldocu
histori
epizoot
infect
especi
europ
vitro
experi
reveal
sulphat
ps
significantli
reduc
number
lytic
plaqu
vivo
heparin
protect
mice
pseudorabi
viru
term
biolog
pathogenet
properti
herp
virus
fall
natur
sever
subfamili
group
includ
cytomegaloviru
cmv
although
detail
classif
present
prematur
nevertheless
cmv
clearli
constitut
group
intern
consist
human
cmv
togeth
one
agent
respons
opportunist
infect
hivinfect
peopl
seen
present
review
sulphat
ps
show
antivir
activitiy
envelop
virus
vitro
suggest
antivir
mechan
depend
polyanion
properti
interact
posit
charg
amino
acid
sequenc
viral
envelop
glycoprotein
natur
sulphat
ps
act
potent
inhibitor
cmv
cell
wall
mucilag
seawe
known
rich
sulphat
ps
potenti
anticmv
activ
recent
blinkovaa
review
inform
spiridina
platensi
bluegreen
alga
divers
biolog
activ
prepar
obtain
alga
found
activ
sever
envelop
virus
includ
cmv
reveal
calcium
spirulan
sulphat
ps
isol
spirulina
platensi
select
inhibit
penetr
viru
host
cell
retent
molecular
conform
chelat
calcium
ion
sulphat
group
may
indispens
antivir
effect
antivir
activ
polysaccharid
fraction
obtain
anoth
red
seawe
nothogenia
fastigiata
also
report
mode
action
cmv
could
ascrib
inhibitori
effect
viru
adsorpt
natur
sourc
sulphat
ps
includ
brown
alga
sulphat
polysaccharid
potent
anticmv
activ
isol
brown
alga
sargassum
horneri
timeofaddit
experi
suggest
inhibit
initi
stage
viral
infect
attach
penetr
host
cell
also
later
replic
stage
viru
penetr
fraction
fiicoidan
anoth
polysaccharid
isol
brown
seawe
leathesia
difformi
also
found
select
antivir
agent
human
cmv
compound
offer
great
promis
candid
drug
chemotherapi
cmv
infect
novel
sulphat
ps
chemic
prepar
ps
terrestri
plant
also
report
anticmv
agent
exampl
ps
three
plant
speci
astragalu
brachycentru
c
astragalu
echidnaeformi
sirjaev
sterculia
uren
roxb
devoid
vitro
antivir
activ
evalu
mous
model
murin
cmv
infect
treatment
compound
need
start
one
day
prior
viru
inocul
maximum
protect
benefit
treatment
start
viru
inocul
ineffect
mannosespecif
plant
ps
orchid
speci
cymbidium
hybrid
cym
epipacti
helleborin
l
crantz
listera
ovata
l
rbr
svenska
potent
select
inhibitor
human
cmv
vitro
presum
interact
level
virion
fusion
target
cell
papillomavirus
member
papopaviru
famili
distinguish
member
virtu
associ
varieti
wart
differ
part
bodi
type
implic
genit
wart
cervic
carcinoma
other
seem
associ
distinct
wart
elsewher
gener
effect
control
avail
although
potenti
danger
lesion
remov
cryosurgeri
laser
treatment
howev
medicin
plant
prepar
report
benefici
conceiv
may
work
promot
heal
stimul
immun
respons
rather
directli
inhibit
viru
natur
highmolecular
weight
sulphat
sulphon
ps
cellulos
sulphat
dextran
sulphat
may
useftil
nontox
microbicid
compound
activ
varieti
sexuallytransmit
diseas
agent
includ
bovin
papillomaviru
type
human
papilloma
viru
type
type
hepat
b
viru
hbv
widespread
throughout
human
popul
special
asia
africa
estim
million
carrier
exist
eventu
expect
develop
liver
carcinoma
cirrhosi
hbv
show
strict
tropism
liver
hepatocyt
display
protect
replic
result
foci
liver
necrosi
viru
member
hepadnavirida
along
sever
speci
replic
mechan
appear
uniqu
famili
contrast
hepat
viru
picornaviru
hepat
agent
appear
viroidlik
rna
enclos
within
hepat
b
capsid
consequ
depend
upon
associ
hbv
spread
surviv
control
may
effect
passiv
immun
hyperimmun
globulin
variou
type
vaccin
current
develop
improv
specif
chemotherapi
consist
success
countri
eg
india
china
plant
extract
provid
success
among
natur
antivir
agent
carbohydr
natur
sulphat
ps
x
k
carrageenan
show
potent
inhibitori
effect
replic
hbv
human
hepatoma
cell
line
two
type
carrageenan
result
concentrationdepend
reduct
hbvantigen
express
hbv
infect
emerg
promis
candid
chemotherapi
acut
hepat
human
rotaviru
hrv
member
reovirida
nonenvelop
viru
major
etiolog
agent
sever
dehydr
gastroenter
children
worldwid
treatment
rotaviru
gastroenter
intraven
fluid
administr
use
success
dehydr
diarrhoea
howev
case
sever
inpati
immunocompromis
host
suffer
prolong
diarrhoea
fever
virusspecif
treatment
necessari
possibl
sever
compound
biomateri
plant
extract
found
inhibitori
hrv
speci
vitro
exampl
extract
stevia
rebaudiana
bertoni
famili
member
chrysanthemum
origin
paraguay
south
america
inhibit
replic
four
serotyp
hrv
vitro
bind
assay
radiolabel
purifi
virus
indic
inhibitori
mechan
plant
extract
blockag
viru
bind
inhibitori
compon
stevia
rebaudiana
found
heterogen
anion
ps
differ
ion
charg
influenza
continu
signific
impact
public
health
annual
death
hospit
attribut
flu
unit
state
alon
airborn
transmiss
facil
viral
mutat
vaccin
shortag
actual
perceiv
side
effect
limit
vaccin
prophylact
drug
contribut
drive
new
therapi
prevent
medicin
influenza
research
last
fifteen
year
elucid
mani
mechan
influenza
viru
invad
captur
mobil
replic
capabl
host
cell
provid
new
target
search
antivir
treatment
past
decad
besid
varieti
synthet
antivir
drug
differ
molecular
target
larg
number
phytochem
recogn
control
infect
caus
influenza
viru
serkedjieva
et
al
report
antivir
activ
lyophil
infus
flower
sambucu
nigra
l
aerial
part
hypericum
perforatum
l
root
saponaria
officinali
l
prepar
contain
ps
could
respons
antivir
properti
report
antiinfluenza
viru
activ
natur
ps
record
literatur
pine
cone
extract
pinu
parviflora
sieb
et
zucc
acid
polysaccharid
isol
compound
show
signific
inhibit
viral
protein
synthesi
infect
cell
virionassoci
rnadepend
rna
polymeras
activ
anim
model
vivo
mice
inocul
intranas
intracerebr
lethal
dose
influenza
viru
die
within
day
howev
infect
viru
preincub
polysaccharid
prepar
cone
pinu
parviflora
significantli
reduc
sakagami
et
review
potenti
antivir
efficaci
natur
polysaccharidicrel
materi
isol
pine
cone
extract
sulphat
ps
potent
antivir
agent
also
evalu
vitro
inhibitor
influenza
viru
replic
fact
sulphat
ps
inhibitori
myxovirus
retrovirus
other
seem
depend
composit
amino
acid
sequenc
viral
envelop
glycoprotein
involv
viruscel
bind
fiision
seen
present
review
natur
sourc
antivir
sulphat
ps
includ
marin
environ
sulphat
nonsulph
ps
antiinfluenza
activ
isol
marin
sourc
green
marin
alga
ulva
lactuca
l
japanes
sea
alga
crenomytilu
grayanu
dunkei
bluegreen
alga
spirulina
platensi
red
seawe
nothogenia
fastigiata
marin
microalga
cochlodinium
polykrikoid
novel
marin
ps
prove
potent
select
inhibitor
influenza
viru
vitro
chemic
synthes
measl
viru
mv
paramyxoviru
associ
sever
chronic
diseas
sinc
advent
mass
immun
campaign
incid
measl
decreas
dramat
mani
develop
countri
case
elsewher
howev
viru
still
take
toll
larg
number
especi
malnourish
immunocompromis
individu
secondari
bacteri
infect
preval
popul
although
infect
rel
shortliv
innocu
healthi
individu
enceph
develop
approxim
case
henc
vaccin
desir
follow
respiratori
infect
viru
readili
invad
local
lymphoid
tissu
gain
access
blood
dissemin
wide
bodi
much
demand
chemotherapi
vaccin
seem
choic
realli
effect
antivir
evalu
although
plant
compound
shown
inhibit
mv
replic
effect
ps
bluegreen
alga
spirulina
platensi
rabi
long
recogn
scourg
livestock
occasion
often
fatal
intrus
human
pet
initi
viru
gain
access
muscl
sensori
organ
skin
replic
local
unmyelin
sensori
nerv
fiber
mani
layer
epitheli
cell
suscept
viru
princip
target
unprotect
neuron
brain
damag
done
result
familiar
psychomotor
disturb
addit
viru
spread
salivari
gland
axoplasm
flow
secret
asinar
mucou
cell
transmit
victim
object
much
research
rabi
viru
develop
better
vaccin
therapeut
measur
natur
sourc
exampl
differ
natur
polymer
carbohydr
inhibit
rabi
viru
infect
chickenembryorel
cell
interf
viru
adsorpt
process
charg
densiti
polymer
backbon
molecul
seem
play
role
influenc
antivir
properti
wherea
featur
sugar
moieti
appear
relev
rubella
sole
member
rudiviru
genu
togaviru
famili
viru
transmit
respiratori
rout
multipli
upper
respiratori
tissu
gain
access
blood
accompani
sometim
characterist
rash
symptom
infect
may
sever
pregnant
women
vaccin
programm
place
mani
countri
belief
viru
eventu
brought
control
although
seem
appar
role
need
specif
antivir
therapi
report
antirubella
activ
natur
product
extract
report
exampl
natur
carbohydr
scleroglucan
three
sulphat
deriv
dextran
sulphat
investig
inhibitori
effect
rubella
viru
infect
vero
cell
result
indic
ps
block
step
viru
replic
subsequ
viru
attach
internalis
andor
uncoat
bunyaviru
sandfli
fever
sicilian
viru
sfsv
phleboviru
member
bunyavirida
famili
caus
acut
incapacit
selflimit
diseas
man
major
impact
europ
middl
east
africa
sfsv
viru
close
relat
virus
consider
pathogen
human
anim
african
swine
fever
viru
asfv
crimeancongo
haemorrhag
fever
viru
cchfv
asfv
highli
contagi
bunyaviru
infect
pig
clinic
indistinguish
unrel
hog
cholera
viru
sinc
epidem
record
intermitt
sever
european
countri
border
mediterranean
caribbean
brazil
recent
european
countri
part
africa
although
pig
appear
speci
infect
natur
viru
adapt
grow
varieti
cell
type
experiment
infect
goat
rabbit
view
seem
worthwhil
consid
possibl
natur
persist
anim
swine
man
transmiss
asfv
usual
occur
respiratori
rout
follow
inhal
viru
invad
attack
local
lymph
node
endothelium
blood
vessel
resuh
high
titer
viru
circul
blood
lymph
eventu
variou
secretori
fluid
attempt
made
produc
vaccin
without
much
success
case
viru
mutat
frequent
wild
crossprotect
anim
complet
sinc
virion
contain
sever
enzym
activ
dna
probabl
code
infect
cell
possibl
specif
chemotherapi
along
line
antiherp
chemic
profit
sever
studi
undertaken
develop
drug
could
use
treatment
fever
infect
caus
virus
belong
bunyavirida
famili
includ
natur
ps
antivir
activ
estim
reduct
cytophat
effect
sfsv
infect
vero
cell
sever
ps
carrageenan
fucoidan
dextran
sulphat
pentosan
polysulph
caus
concentrationdepend
reduct
viru
yield
fabrega
et
al
screen
sever
extract
marin
microalga
vitro
inhibit
replic
asfv
inhibit
could
due
sulphat
ps
suggest
pattern
viral
inhibit
obtain
use
exocellular
extract
microalga
enrich
compound
andor
dextran
sulphat
high
molecular
weight
natur
ps
consid
potenti
treatment
signific
human
infect
caus
bunyavirus
mous
model
punta
toro
viru
phleboviru
member
bunyavirida
famili
model
studi
treatment
rift
valley
fever
infect
tragacanthin
ps
astragalu
brachycentru
astragalu
echidnaeformi
plant
caus
reduct
mortal
liver
infect
score
liver
spleen
viru
titer
serum
transaminas
treat
mice
poliomyel
scourg
thank
improv
hygien
practic
effect
block
spread
wildtyp
poliovirus
especi
develop
countri
thank
widespread
use
vaccin
virus
like
enterovirus
transmit
fecalor
rout
follow
ingest
replic
variou
cell
type
pharynx
small
intestin
quit
stabl
stomach
acid
gain
access
circul
dissemin
occasion
gain
access
central
nervou
system
may
produc
characterist
lesion
lead
poliomyel
control
viru
spread
accompani
vaccin
continu
provid
best
mean
allevi
poliomyel
use
antivir
seem
less
applic
mani
viral
infect
although
polioviru
continu
serv
use
laboratori
model
antivir
screen
plant
kingdom
seawe
may
sourc
potenti
use
interest
antivir
compound
poliovirus
exampl
antipolioviru
activ
detect
polysaccharidicrich
fraction
extract
sever
korean
seawe
leav
meliacea
tree
trichilia
glabra
compound
carbohydr
natur
antivir
activ
virus
isol
natur
sourc
sever
compound
belong
differ
class
sulphat
ps
evalu
inhibitori
effect
replic
arenaviru
junin
tacarib
vero
cell
potent
select
inhibitor
sulphat
ps
dextran
sulphat
carrageenan
fucoidan
heparin
pentosan
polysulph
exampl
also
includ
alo
polymannos
high
mannos
purifi
alo
barbadensi
miller
plant
show
activ
enhanc
antibodi
titer
coxsackieviru
myocard
murin
model
diseas
fungal
ps
activ
vivo
sendai
viru
infect
although
rel
littl
work
done
natur
antivir
plant
virus
sever
report
concern
antivir
activ
plant
viru
infect
record
exampl
yeast
mannan
antivir
activ
tobacco
mosaic
viru
infect
tobacco
plant
lichenan
ps
iceland
moss
exhibit
antivir
activ
potato
virus
